Table 5.

General diseases in terms of their occurrence for all respondents, separated by gender. An asterisk after the chi² value symbolizes the significance level (* p< 0.05, ** p < 0.01, *** p < 0.001). An ‘^a’ stands behind the chi² test, if Fisher’s exact test was applied when 20% of the cells of a contingency table were below 5.

Disease	Occurrence n (%)				Occurrence before Start of Profession n (%)				Occurrence after Start of Profession n (%)				Occurrence after xx Years Min/Max
	Total	Female	Male	Chi2 Female/Male	Total	Female	Male	Chi2 Female/Male	Total	Female	Male	Chi2 Female/Male	Total	Female	Male
Total n (%)	146 (32.4)	91 (31.7)	55 (33.7)	0.676
Rheumatism	3 (0.7)	2 (0.7)	1 (0.6)	1.000 a	1 (0.2)	0 (0)	1 (0.6)	0.362 a	2 (0.4)	2 (0.7)	0 (0)	0.537 a	18/20	18/20
Arthrosis	20 (4.4)	10 (3.5)	10 (6.1)	0.234	3 (0.7)	2 (0.7)	1 (0.6)	1.000 a	14 (3.1)	6 (2.1)	8 (4.9)	0.155	5/35	5/20	5/35
Carpal Tunnel Syndrome	14 (3.1)	11 (3.8)	3 (1.8)	0.276	3 (0.7)	2 (0.7)	1 (0.6)	1.000 a	9 (2.0)	7 (2.4)	2 (1.2)	0.498 a	2/20	2/20	15/20
Disc Prolapse	35 (7.8)	20 (7)	15 (9.2)	0.464	7 (1.6)	6 (2.1)	1 (0.6)	0.430 a	22 (4.9)	10 (3.5)	12 (7.4)	0.073	2/40	2/22	4/40
Tendovaginitis	34 (7.6)	21 (7.3)	13 (8)	0.853	10 (2.2)	7 (2.4)	3 (1.8)	1.000 a	21 (4.7)	12 (4.2)	9 (5.5)	0.643	1/30	1/23	5/30
Flexor Tendovaginitis	4 (0.9)	3 (1)	1 (0.6)	1.000 a	0(0)	0 (0)	0 (0)	_____	2 (0.4)	1 (0.3)	1 (0.6)	1.000	6/20	6/20
Cubital Tunnel Syndrome	0 (0)	0 (0)	0 (0)	______	0 (0)	0 (0)	0(0)	_____	0 (0)	0(0)	0 (0)	_______	_______	______	______
Cervical Spine Syndrome	57 (12.7)	41 (14.3)	16 (9.8)	0.187	15 (3.3)	11 (3.8)	4 (2.5)	0.588	31 (6.9)	20 (7)	11 (6.7)	1.000	1/27	1/27	1/25
Thoracic Spine Syndrome	14 (3.1)	11 (3.8)	3 (1.8)	0.276	1 (0,2)	1 (0.3)	0 (0)	1.000 a	10 (2.2)	7 (2.4)	3 (1.8)	1.000 a	1/25	1/25	10/15
Lumbar Spine Syndrome	44 (9.8)	27 (9.4)	17 (10.4)	0.743	10 (2.2)	8 (2.8)	2 (1.2)	0.341 a	29 (6.4)	16 (5.6)	13 (8)	0.425	1/401	1/20	3/40